AVI BioPharma, Inc. (AVII) – FDA
-
AVI BioPharma (AVII) Receives FDA Orphan Drug Status for Ebola Prevention Drug
-
AVI BioPharma (AVII) Says Eteplirsen Met Primary Endpoint in DMD Following Phase IIb Trial
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AVII Stock Lookup